|
Re: Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
4
|
Resverlogix Corp.
|
Nov 04, 2019 10:01AM
|
|
Protecting shares from being borrowed by shorts
|
4
|
Resverlogix Corp.
|
May 18, 2018 11:37AM
|
|
Competition from Constellation
|
4
|
Zenith Epigenetics
|
Dec 13, 2017 09:01AM
|
|
Trading volumes
|
4
|
Resverlogix Corp.
|
Jul 20, 2016 07:42PM
|
|
Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 02:00PM
|
|
Re: The Top 5 TSX Biotechs for 2018 so far - Guess which one they missed.....
|
4
|
Resverlogix Corp.
|
Dec 25, 2018 02:13PM
|
|
Re: Zenith AGM Dec 15
|
4
|
Zenith Epigenetics
|
Oct 17, 2016 08:00PM
|
|
Re: Strong versus weak hands....
|
4
|
Resverlogix Corp.
|
Aug 08, 2015 08:38PM
|
|
Re: What's going on?
|
4
|
Resverlogix Corp.
|
Sep 11, 2019 12:02PM
|
|
Why Hepalink in the first place?
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 07:38PM
|
|
Redistributing BRD4 in inflammation
|
4
|
Resverlogix Corp.
|
Jul 01, 2015 08:50PM
|
|
Re: RVX ...looking bullish
|
4
|
Resverlogix Corp.
|
Aug 19, 2015 07:26PM
|
|
Re: Today is opposite day, seeing bid/ask both at $3.06....
|
4
|
Resverlogix Corp.
|
Aug 22, 2019 11:44AM
|
|
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
4
|
Zenith Epigenetics
|
Dec 14, 2016 04:34PM
|
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jun 10, 2019 08:27PM
|
|
Re: BMO Current Value at 0
|
4
|
Zenith Epigenetics
|
Oct 31, 2018 02:15PM
|
|
Nice background article on mCRPC
|
5
|
Zenith Epigenetics
|
Oct 02, 2016 08:29PM
|
|
Re: Richmond Club presentation
|
5
|
Resverlogix Corp.
|
Mar 30, 2016 03:12PM
|
|
BET Inhibitors may help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
|
5
|
Zenith Epigenetics
|
Jun 22, 2021 09:34AM
|
|
Re: How I See It
|
5
|
Resverlogix Corp.
|
May 04, 2016 04:33PM
|
